Target intelligence / Profile preview

Ciliary muscle

Molecular classification
Other (Smooth muscle; not a receptor, enzyme, transporter, or typical molecular target)
01

Overview

The **ciliary muscle** is a smooth muscle structure in the eye, located within the ciliary body of the uveal tract[4][1]. It is responsible for **controlling ocular accommodation**, the process by which the lens changes shape to focus on near or distant objects. The muscle is innervated mainly by parasympathetic fibers from the oculomotor nerve (cranial nerve III), acting through M3 muscarinic receptors. Contraction of the ciliary muscle reduces tension on the zonular fibers, making the lens rounder for near vision (accommodation); relaxation allows the lens to flatten for distance vision[1][4]. It also participates in regulating aqueous humor dynamics by widening the iridocorneal angle and facilitating drainage via the canal of Schlemm[1]. Smooth muscle relaxing or contracting agents affecting the ciliary muscle are important in therapies for glaucoma and in diagnostic mydriasis and cycloplegia[9][6]. Although critical for eye function, the **ciliary muscle itself is not a conventional molecular drug target** like a receptor protein or enzyme; rather, it is a tissue made up of smooth muscle cells. Disorders can involve dysfunction (accommodation problems) or rare tumors, such as mitochondria-rich leiomyoma[8]. It is important to note this entry refers to an anatomical tissue—not a molecular target—and is therefore considered **incorrect as a canonical drug target** under standard pharmacological nomenclature.

Other names
Intrinsic ocular muscleIntraocular muscleEye ciliary muscle
02

Mechanism of action

Muscarinic receptor (primarily M3) activation (contraction), muscarinic receptor blockade (relaxation/cycloplegia), Beta-adrenergic blockade (modulation of autonomic tone)

03

Biological functions

Accommodation (lens shape control)Regulation of aqueous humor flowFacilitation of outflow via iridocorneal angleLocal proprioception
04

Disease associations

GlaucomaOcular accommodation disorders (presbyopia)Ciliary body tumors (rare, e.g., leiomyoma)
05

Safety considerations

Drug-induced cycloplegia or blurred visionRisk of increased intraocular pressure in susceptible patientsRare tumors of smooth muscle origin (leiomyoma)
06

Interacting drugs

Muscarinic agonists (pilocarpine)

3 more in the full profile.

Beyond the preview

Go deeper on Ciliary muscle.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ciliary muscle.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call